Brand Name: Novasight Hybrid System Product Name: Novasight Hybrid Catheter Model/Catalog Number: TA-06-0001 Product Description: Common Name: Diagnostic intravascular catheter Description: The Novasight Hybrid catheter is a 3Fr single use, sterile device, which will be able to perform transluminal ultrasound and optical coherence tomography imaging of adults. The catheter is capable of real-time 2D side viewing ultrasound and optical imaging acquired simultaneously providing precisely co-registered images with the ability to produce rapidly post processed rendered longitudinal images of the vessel. Packaging: The Novasight Hybrid Catheter is packaged in a packaging system including the protective packaging and the sterile barrier system.
Publicado el 30 de abril de 2025 · Inicio del retiro: 12 de marzo de 2025
Resumen
FDA registra el retiro Z-1585-2025 de dispositivos médicos de Clase I, publicado el 30 de abril de 2025 e iniciado el 12 de marzo de 2025. Empresa responsable: Conavi Medical Inc.; Estado: En curso; Cantidad reportada: 685; Lote: Model No: TA-06-0001 UDI-DI: (01)00628055603054 Lot number: 230902; Expiration date: 2024-06; Lot number: 240202; Expiration date: 2025-03; Lot number: 240302; Expiration date: 2025-04; Lot number: 240402; Expiration date: 2025-05; Lot number: 240502; Expiration date: 2025-06; and all catheter lots which were expired (See attachment 2a, 2b and 2c for details). La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Due to manufacturing issues there is a potential for the catheter sheath to detach.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Conavi Medical Inc.
- Distribuidor
- US distribution to states of: GA, NY, NJ, OH; and OUS (Foreign) to countries of: Canada and China
- Lote
- Model No: TA-06-0001 UDI-DI: (01)00628055603054 Lot number: 230902; Expiration date: 2024-06; Lot number: 240202; Expiration date: 2025-03; Lot number: 240302; Expiration date: 2025-04; Lot number: 240402; Expiration date: 2025-05; Lot number: 240502; Expiration date: 2025-06; and all catheter lots which were expired (See attachment 2a, 2b and 2c for details).
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- Canada
Retiros relacionados
- FDAZenition 70. The device is to be used in health care facilities both inside and outside the operating room,30 de abril de 2025
- FDAMerit Medical, REF: R2007, EsophyX Z+, (1) Fastener Delivery Device, SterileEO, RxOnly30 de abril de 2025
- FDAVeradius Unity. Product Code 718132. The devices are used for radiological guidance and visualization during30 de abril de 2025
- FDAAmplatzer TorqVue LP Delivery System (TVLP), Model nos. 9-TVLP4F90/060 and 9-TVLP4F90/08030 de abril de 2025
- FDALabel: FROZEN CHOPPED CILANTRO; PACK SIZE: 4 - 8 oz; NET WT: 2 lb; PERISHABLE - KEEP FROZEN; Packaging: 4 - 830 de abril de 2025
- FDAZimmer Biomet Ceramic Head, 22.2 mm Diameter, Type 1, +0 Neck, Model Number 802802202; Prosthesis, Hip,30 de abril de 2025
Preguntas sobre este retiro
¿Brand Name: Novasight Hybrid System Product Name: Novasight Hybrid Catheter Model/Catalog Number: TA-06-0001 Product Description: Common Name: Diagnostic intravascular catheter Description: The Novasight Hybrid catheter is a 3Fr single use, sterile device, which will be able to perform transluminal ultrasound and optical coherence tomography imaging of adults. The catheter is capable of real-time 2D side viewing ultrasound and optical imaging acquired simultaneously providing precisely co-registered images with the ability to produce rapidly post processed rendered longitudinal images of the vessel. Packaging: The Novasight Hybrid Catheter is packaged in a packaging system including the protective packaging and the sterile barrier system. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1585-2025 el 30 de abril de 2025. Peligro reportado: Due to manufacturing issues there is a potential for the catheter sheath to detach.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter